Thirdly, our observations that BRCA1-mutated cells are resistant to IFN-γ-mediated cytotoxicity and to STAT1 downregulation could have implications for understanding responses to anti-tumor immunity in BRCA1-mutated cancers. The gene discussed is STAT1; the disease is neoplasm.